GreenLight Biosciences Holdings filed its 10-K on Mar 28, 2023 for the period ending Dec 31, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
GreenLight Biosciences Holdings
Equities
GRNA
US39536G1058
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+24.49% | 47.96B | |
+0.46% | 42.45B | |
+43.96% | 41.47B | |
+26.04% | 31.6B | |
+20.47% | 28.63B | |
-4.47% | 28.03B | |
+51.68% | 14.56B | |
+44.92% | 14.14B | |
+2.19% | 12.58B |